4basebio PLC

4basebio PLC is developing next generation gene therapy technologies and solutions. 4basebio started with a focus on the manufacture of synthetic DNA for use in gene therapies; their synthetic DNA has clear safety, efficacy, and cost benefits over current plasmid DNA. Their near-term objective is the development of Good Manufacturing Practice (“GMP”) grade synthetic DNA as a key milestone…More in the commercialisation of this core technology.